Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide.

Louwagie EJ, Diego JN, Farooqi CS, Kamal MM.

DOI: 10.1210/jcemcr/luaf028
Published: 2025-02-13
Container: JCEM Case Rep
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1210/jcemcr/luaf028,
  title = {Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide.},
  author = {Louwagie EJ and  Diego JN and  Farooqi CS and  Kamal MM.},
  year = {2025},
  journal = {JCEM Case Rep},
  doi = {10.1210/jcemcr/luaf028},
  url = {https://doi.org/10.1210/jcemcr/luaf028}
}

RIS

TY  - JOUR
TI  - Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide.
AU  - Louwagie EJ
AU  -  Diego JN
AU  -  Farooqi CS
AU  -  Kamal MM.
PY  - 2025
JO  - JCEM Case Rep
DO  - 10.1210/jcemcr/luaf028
UR  - https://doi.org/10.1210/jcemcr/luaf028
ER  -

APA

EJ, L., JN, D., CS, F., & MM., K. (2025). Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide.. JCEM Case Rep. https://doi.org/10.1210/jcemcr/luaf028

Source records

europe-pmc · retrieved 2026-09-26T10:05:59.121Z